22
views
0
recommends
+1 Recommend
0 collections
    2
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Enrolment and logistical challenges in TaMoVac 01 Phase I/II HIV trial despite the completion of an earlier (HIVIS-03 trial trial) in Dar es Salaam

      abstract
      1 , 1 , , 1 , 1 , 2 , 1
      Retrovirology
      BioMed Central
      AIDS Vaccine 2012
      9-12 September 2012

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background Participation of sub-Saharan countries in HIV vaccine trials is important in the fight against HIV/AIDS, and has to be sustained by continued trials. Experiences from earlier trials are expected to influence the design and the performance of subsequent trials. Following completion of HIVIS-03 trial, TaMoVac- 01 trial was initiated. We compare enrolment experiences between the two trials. Methods The HIVIS-03 trial, conducted between 2007 - 2010 recruited 60 volunteers from the Police force in Dar es Salaam. The subsequent TaMoVac- 01 trial has recruited 62 volunteers from the Police and Prisons force, and youths at IDC. Results Enrollment of volunteers into the HIVIS-03 took 12 months while the TaMoVac-01 trial took 13 months. Screened: enrolled ratio was 3:1for HIVIS-03 trail, while for TaMoVac-01 8:1. Reasons for screen-out in the TaMoVac-01 trial were influence of family, misconception, clinical and laboratory abnormalities. Recruitment of females was a challenge in the HIVIS-03 trial, but was unnoticed in the TMV-01 trial, this could be due to inclusion of youths. Misconceptions in the Police force remain an obstacle to recruitment despite regular education sessions. Other challenges were: Poor adherence to schedules, due to competing prioritization of employment requirements; difficulties in communication with volunteers without phones. Most challenges were addressed through collaboration with the concerned authorities in the respective cohorts. Conclusion Recruitment challenges continued in the TMV-01 trial despite our experiences with HIVIS-03 trial. Enhanced Community engagement and timely action by the researchers is necessary to ensure a smooth conduct of the trials.

          Related collections

          Author and article information

          Conference
          Retrovirology
          Retrovirology
          Retrovirology
          BioMed Central
          1742-4690
          2012
          13 September 2012
          : 9
          : Suppl 2
          : P153
          Affiliations
          [1 ]Muhimbili University of Health and Allied Sciences, Tanzania, United Republic of
          [2 ]Karolinska Institutet, Sweden
          Article
          1742-4690-9-S2-P153
          10.1186/1742-4690-9-S2-P153
          3441371
          f5b03eef-31ca-4e06-910a-893b6e33c3f9
          Copyright ©2012 Ngatoluwa et al; licensee BioMed Central Ltd.

          This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

          AIDS Vaccine 2012
          Boston, MA, USA
          9-12 September 2012
          History
          Categories
          Poster Presentation

          Microbiology & Virology
          Microbiology & Virology

          Comments

          Comment on this article